Authors
Latest:
A safe and effective non-ablative treatment with multiple applications for the ocular surfacePlasma emission can act as a therapeutic for blepharitis, dry eye and other ocular disease
Latest:
Dry eye renaissance: Escalating cases meet with innovationFor clinicians, the evolution of treatment is as much a responsibility as an opportunity
Latest:
Digital visual training helps treat disorders associated with close workComputer software platform provides home vision exercises to overcome asthenopia.
Latest:
Is ophthalmology approaching the end of LASIK?Lenticule extraction poses a provocative question–and a complicated answer
Latest:
The 30-year history of optical coherence tomography of the human eyeIn the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
Latest:
Ophthalmology: A pioneer in the field of artificial intelligenceOphthalmology, with its heavy reliance on imaging, is an innovator in the field of artificial intelligence in medicine.
Latest:
Is low vitamin D a risk factor for primary open angle glaucoma?Evidence for a connection between low vitamin D levels and glaucoma is increasing but the link remains speculative and no causal connection has been demonstrated.
Latest:
Not just for eating: Grapes and potatoes help surgery trainees hone skillsThe pandemic has impacted ophthalmic surgical training. Exercises have been developed to provide key skills that can be practised simply at home and require no special equipment.
Latest:
The future of microbial keratitis treatment is brightUltraviolet light’s potential in ocular care extends beyond structural reinforcement to antimicrobial applications, especially for microbial keratitis
Latest:
Use of virtual reality training in amblyopiaVirtual reality dichoptic and perceptual learning training seem to be a useful therapeutic option for achieving a successful visual rehabilitation in amblyopic patients.
Latest:
A new lens option for enhanced monovision performanceIn “modified monovision”, which can be achieved with a new IOL, one eye predominantly manages distance vision and the other near vision—as with standard monovision—but the extended depth of field provides a degree of intermediate vision that is independent of spectacles.
Latest:
YAG-shots in IOLs: Safe or dangerous?Poorly focused YAG shots lead irrevocably to a permanent defect in the IOL material and thus to possible effects on the quality of vision with straylight or glare. In a recent study, the differing amounts of damage that Nd:YAG causes in a range of hydrophilic and hydrophobic acrylic lens materials was assessed.
Latest:
Digital visual training helps treat disorders associated with close workComputer software platform provides home vision exercises to overcome asthenopia.
Latest:
Gene therapy heralds new era for inherited retinal diseasesGene therapies are being investigated for multiple inherited retinal diseases and the progress in this field has implications for patient care.
Latest:
Optimising the ocular surface to achieve good vision after surgeryPatients need to pay attention to their eye health over the long term.
Latest:
Better IOL calculation in post-LASIK eyesTo heighten precision, use total keratometry, not imaginary numbers
Latest:
Corneal crosslinking outcomes appear to justify its use in paediatricsStudies show that corneal crosslinking could be a beneficial treatment in paediatric patients with keratoconus.
Latest:
Choosing the specular microscope that fits your clinicAssessing two devices in a real-world setting
Latest:
Amblyopia screening with the dynamic random dot stereotestA new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.
Latest:
Diabetic eye disease: Where are we now?Clinicians must consider redefining the metrics and intention behind functional outcomes, according to experts from the European Association for the Study of Diabetic Eye Complications
Latest:
YAG-shots in IOLs: Safe or dangerous?Poorly focused YAG shots lead irrevocably to a permanent defect in the IOL material and thus to possible effects on the quality of vision with straylight or glare. In a recent study, the differing amounts of damage that Nd:YAG causes in a range of hydrophilic and hydrophobic acrylic lens materials was assessed.
Latest:
Learnings from Real World Evidence of Faricimab in nAMD and DME: Part 2Arshad M. Khanani, MD, MA, FASRS, highlights the fluid resolution with faricimab and the need for loading doses, especially in high-needs switch patients with nAMD or DME.
Latest:
Surgical options for normalising neuroadaptationIt is important to select good candidates for presbyopia-correcting IOL implantation and frankly discuss postoperative adjustment issues for a successful outcome.
Latest:
Restoring vision through retinal ganglion cell repopulationRGC replacement represents a more formidable challenge.
Latest:
Dry AMD: A review of ongoing, completed and future treatmentsThe most promising recent interventional trials for investigational therapies in dry age-related macular degeneration are highlighted by the authors.
Latest:
ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops (Myatro XL)According to a press release, Myatro XL is the first 0.05% atropine eye drop for paediatric myopia control.
